Prelude Therapeutics Stock Technical Analysis
| PRLD Stock | USD 1.05 0.07 7.14% |
As of the 1st of December, Prelude Therapeutics holds the Coefficient Of Variation of (302.72), variance of 43.34, and Risk Adjusted Performance of (0.24). Compared to fundamental indicators, the technical analysis model allows you to check existing technical drivers of Prelude Therapeutics, as well as the relationship between them. Please check Prelude Therapeutics coefficient of variation, treynor ratio, as well as the relationship between the Treynor Ratio and skewness to decide if Prelude Therapeutics is priced some-what accurately, providing market reflects its current price of 1.05 per share. Given that Prelude Therapeutics is a hitting penny stock territory we advise to closely look at its jensen alpha.
Prelude Therapeutics Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Prelude, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to PreludePrelude |
Prelude Therapeutics Analyst Consensus
| Target Price | Advice | # of Analysts | |
| 7.75 | Buy | 5 | Odds |
Most Prelude analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Prelude stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Prelude Therapeutics, talking to its executives and customers, or listening to Prelude conference calls.
Prelude Therapeutics technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Prelude Therapeutics Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Average True Range was developed by J. Welles Wilder in 1970s. It is one of components of the Welles Wilder Directional Movement indicators. The ATR is a measure of Prelude Therapeutics volatility. High ATR values indicate high volatility, and low values indicate low volatility.
Prelude Therapeutics Trend Analysis
Use this graph to draw trend lines for Prelude Therapeutics. You can use it to identify possible trend reversals for Prelude Therapeutics as well as other signals and approximate when it will take place. Remember, you need at least two touches of the trend line with actual Prelude Therapeutics price movement. To start drawing, click on the pencil icon on top-right. To remove the trend, use eraser icon.Prelude Therapeutics Best Fit Change Line
The following chart estimates an ordinary least squares regression model for Prelude Therapeutics applied against its price change over selected period. The best fit line has a slop of 0.05 , which may suggest that Prelude Therapeutics market price will keep on failing further. It has 122 observation points and a regression sum of squares at 92.18, which is the sum of squared deviations for the predicted Prelude Therapeutics price change compared to its average price change.About Prelude Therapeutics Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Prelude Therapeutics on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Prelude Therapeutics based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Prelude Therapeutics price pattern first instead of the macroeconomic environment surrounding Prelude Therapeutics. By analyzing Prelude Therapeutics's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Prelude Therapeutics's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Prelude Therapeutics specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2021 | 2022 | 2023 | 2024 (projected) | Current Ratio | 15.37 | 9.42 | 10.79 | 8.74 | Net Debt To EBITDA | 0.27 | 0.24 | 0.0641 | 0.0609 |
Prelude Therapeutics December 1, 2024 Technical Indicators
Most technical analysis of Prelude help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Prelude from various momentum indicators to cycle indicators. When you analyze Prelude charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.24) | |||
| Market Risk Adjusted Performance | (1.82) | |||
| Mean Deviation | 4.05 | |||
| Coefficient Of Variation | (302.72) | |||
| Standard Deviation | 6.58 | |||
| Variance | 43.34 | |||
| Information Ratio | (0.35) | |||
| Jensen Alpha | (2.34) | |||
| Total Risk Alpha | (3.28) | |||
| Treynor Ratio | (1.83) | |||
| Maximum Drawdown | 51.12 | |||
| Value At Risk | (7.83) | |||
| Potential Upside | 6.25 | |||
| Skewness | (3.51) | |||
| Kurtosis | 21.48 |
Complementary Tools for Prelude Stock analysis
When running Prelude Therapeutics' price analysis, check to measure Prelude Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Prelude Therapeutics is operating at the current time. Most of Prelude Therapeutics' value examination focuses on studying past and present price action to predict the probability of Prelude Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Prelude Therapeutics' price. Additionally, you may evaluate how the addition of Prelude Therapeutics to your portfolios can decrease your overall portfolio volatility.
| Performance Analysis Check effects of mean-variance optimization against your current asset allocation | |
| Financial Widgets Easily integrated Macroaxis content with over 30 different plug-and-play financial widgets | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Positions Ratings Determine portfolio positions ratings based on digital equity recommendations. Macroaxis instant position ratings are based on combination of fundamental analysis and risk-adjusted market performance |